- US equities tumbled on Friday as investors balked at wild Reddit-fueled volatility.
- Day traders drove GameStop, AMC, and others higher after brokers removed some trading restrictions.
- Johnson & Johnson said its coronavirus vaccine was 66% effective but suggested it was less beneficial against the strain first identified in South Africa.
- Sign up here for our daily newsletter, 10 Things Before the Opening Bell.
US stocks capped their worst week since October on Friday as Reddit day traders continued to furiously attack shorts and drive massive volatility.
GameStop, AMC, and other Reddit-favorite stocks soared as day traders piled back into their risky positions. The highly volatile names enjoyed strong buying throughout the week. Moves by Robinhood, Interactive Brokers, and other platforms to restrict trading temporarily cut into gains before rallies on Friday pared losses.
Market participants fear that the retail traders' targeting of shorts could force hedge funds to cover their bearish bets by selling their long positions. While the phenomenon has rocked only some funds, strategists have raised concerns about a growing market disruption.
Here's where US indexes stood at the 4 p.m. ET close on Friday:
- S&P 500: 3,714.04, down 1.94%
- Dow Jones industrial average: 29,980.84, down 2.03% (622.52 points)
- Nasdaq composite: 13,070.69, down 2.00%
"Chasing the squeeze is like buying a lottery ticket. You might profit, but you might also lose everything," said Lindsey Bell, the chief investment strategist at Ally Invest. "This type of speculative trading is more about luck and less about skill."
The Securities and Exchange Commission said Friday that it was monitoring recent market volatility for signs of wrongdoing. Stocks' wild price swings risk exposing investors to "rapid and severe losses" and undermining overall confidence, the agency said.
The Dow briefly sank below 30,000 for the first time since January 4 before partially recovering. Energy and tech stocks were the session's worst performers. Healthcare and utilities outperformed. Still, all 11 S&P 500 sectors sank into the close.
Cboe's VIX - a popular measure of market volatility - surged to its highest level since October. The index reached an intraday high of 37.51 before closing just below 31.
Investors also sold off on less-than-ideal news from a trial of Johnson & Johnson's coronavirus vaccine. The pharma giant announced on Friday that its single-dose vaccine was found to be 66% effective, well below the efficacy demonstrated by other companies' two-dose programs. Johnson & Johnson said its vaccine was also less effective in South Africa, suggesting the shot is less beneficial at protecting against the more contagious virus strain first identified in that country.
Stocks soared to record highs throughout January on the hopes that vaccine rollouts and stimulus from the Biden administration could accelerate the US economic rebound. Johnson & Johnson's announcement underscored the difficulty in ending the pandemic and reaching herd immunity. Shares fell on the news.
Novavax leaped after a UK trial of its coronavirus vaccine found that the shot was 89% effective at protecting against illness. The vaccine was also found to be effective against the virus variants first identified in the UK and South Africa.
Bitcoin surged above $38,500 for the first time since January 15 after Tesla CEO Elon Musk added "#bitcoin" to his Twitter bio. Selling promptly pulled prices lower, and bitcoin traded at about $34,750 when
Spot gold climbed as much as 1.6%, to $1,875.71 per ounce. The US dollar strengthened slightly against a basket of Group-of-20 currency peers, and Treasury yields edged higher.
Oil traded mixed. West Texas Intermediate crude fell as much as 0.8%, to $51.93 per barrel. Brent crude, oil's international benchmark, rose 1.5%, to $56.35 per barrel, before paring gains.
Now read more markets coverage from Markets Insider and Business Insider:
US GDP grew by a weaker-than-expected 4% in the 4th quarter as COVID-19 cases soared
Citron Research says it will stop publishing short-seller research after the GameStop squeeze
MORGAN STANLEY: Buy these 8 stocks set to crush their upcoming Q4 earnings